| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity, 2018 | 4547 | 2018 |
| The Immune Landscape of Cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 51 (2), 411-412, 2019 | 4546 | 2019 |
| Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell Reports 18 (11), 2780-2794, 2017 | 651 | 2017 |
| Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ... Cancer Cell, 2018 | 495 | 2018 |
| Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers X Peng, Z Chen, F Farshidfar, X Xu, PL Lorenzi, Y Wang, F Cheng, L Tan, ... Cell reports 23 (1), 255, 2018 | 239 | 2018 |
| A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 148 | 2018 |
| Serum metabolomic profile as a means to distinguish stage of colorectal cancer F Farshidfar, AM Weljie, K Kopciuk, WD Buie, A MacLean, E Dixon, ... Genome medicine 4 (5), 42, 2012 | 133 | 2012 |
| Germline genetic contribution to the immune landscape of cancer RW Sayaman, M Saad, V Thorsson, D Hu, W Hendrickx, J Roelands, ... Immunity 54 (2), 367-386. e8, 2021 | 121 | 2021 |
| A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics F Farshidfar, AM Weljie, KA Kopciuk, R Hilsden, SE McGregor, WD Buie, ... British Journal of Cancer 115 (7), 848-857, 2016 | 121 | 2016 |
| Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment D Hao, MO Sarfaraz, F Farshidfar, DG Bebb, CY Lee, CM Card, M David, ... Metabolomics 12 (3), 58, 2016 | 76 | 2016 |
| Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma OS Falegan, MW Ball, RA Shaykhutdinov, PM Pieroraio, F Farshidfar, ... Metabolites 7 (1), 6, 2017 | 61 | 2017 |
| Type 3 inositol 1, 4, 5‐trisphosphate receptor is increased and enhances malignant properties in cholangiocarcinoma P Ueasilamongkol, T Khamphaya, MT Guerra, MA Rodrigues, DA Gomes, ... Hepatology 71 (2), 583-599, 2020 | 54 | 2020 |
| Patterns of extremity traumas leading to amputation in Iran: results of Iranian National Trauma Project M Moini, MR Rasouli, A Khaji, F Farshidfar, P Heidari Chinese Journal of Traumatology (English Edition) 12 (2), 77-80, 2009 | 54 | 2009 |
| Detection of adulteration in Iranian saffron samples by 1H NMR spectroscopy and multivariate data analysis techniques R Dowlatabadi, F Farshidfar, Z Zare, M Pirali, M Rabiei, MR Khoshayand, ... Metabolomics 13 (2), 19, 2017 | 45 | 2017 |
| From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer OF Bathe, F Farshidfar Genes 5 (3), 536-560, 2014 | 43 | 2014 |
| Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent N Esmaili, C Chams-Davatchi, M Valikhani, F Farshidfar, N Parvaneh, ... European Journal of Dermatology 18 (2), 159-164, 2008 | 41 | 2008 |
| Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes F Grafton, J Ho, S Ranjbarvaziri, F Farshidfar, A Budan, S Steltzer, ... Elife 10, e68714, 2021 | 36 | 2021 |
| A quantitative multimodal metabolomic assay for colorectal cancer F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor, VC Mazurak, WD Buie, ... BMC Cancer 18 (1), 26, 2018 | 36 | 2018 |
| A Framework for Development of Useful Metabolomic Biomarkers and Their Effective Knowledge Translation C Marchand, F Farshidfar, J Rattner, O Bathe Metabolites 8 (4), 59, 2018 | 32 | 2018 |
| Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11. 21 to metastasis F Farshidfar, K Rhrissorrakrai, C Levovitz, C Peng, J Knight, ... Nature communications 13 (1), 1-16, 2022 | 27 | 2022 |
Oliver BatheProfessor of Surgery and Oncology, University of Calgary在 ucalgary.ca 的电子邮件经过验证
